GN Hearing—the hearing-aid division of GN Store Nord which includes ReSound , Beltone , and Jabra Enhance —recorded a modest decline in the second quarter of 2026, as weakness at a major U.S. customer offset stronger performance outside the United States....
Continue reading at Hearing Tracker
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a corporate financial update with no direct bearing on clinical practice.
The GN–Amplifon deal, if completed, could reshape distribution and brand access for independent audiology clinics that carry ReSound products.
- 01GN Hearing posted a modest Q2 2026 sales decline vs. the prior year period.
- 02Weakness was attributed to reduced purchasing by a major U.S. customer.
- 03The pending Amplifon acquisition of GN Hearing continues to advance.
- 04Amplifon is one of the world's largest retail hearing-care chains, making this a significant industry consolidation move.
- 05No product, clinical, or regulatory changes were announced alongside the financial results.
GN Hearing experienced a Q2 2026 sales decline attributed to weakness at a major U.S. customer.
press releasepartially supportedThe pending acquisition deal between GN Hearing and Amplifon continues to advance.
press releasesupported
